Century Therapeutics Inc (IPSC)
Century Therapeutics Announces New Beta Islet Program for Type 1 Diabetes
Q32 Bio Inc (QTTB)
Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Becton Dickinson and Company (BDX)
Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH
Protalix BioTherapeutics Inc. (PLX)
Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results
Merck & Company Inc (MRK)
Merck to Participate in the Jefferies Global Healthcare Conference in London
Immunic Inc (IMUX)
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Henry Schein Inc (HSIC)
Henry Schein to Participate in Upcoming Investor Conference in December
DarioHealth Corp (DRIO)
DarioHealth Reports Third Quarter 2025 Financial and Operating Results
Zura Bio Ltd (ZURA)
Zura Bio Reports Third Quarter 2025 Financial Results and Recent Corporate Updates
Serina Therapeutics, Inc. (SER)
Serina Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Highlights